Article
Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients.
Blood cancer journal - 26 Feb 2016
Kortuem K M, Braggio E, Bruins L, Barrio S, Shi C S, Zhu Y X, Tibes R, Viswanatha D, Votruba P, Ahmann G, Fonseca R, Jedlowski P, Schlam I, Kumar S, Bergsagel P L, Stewart A K
Abstract excerpt
We employed a customized Multiple Myeloma (MM)-specific Mutation Panel (M(3)P) to screen a homogenous cohort of 142 untreated MM patients for relevant mutations in a selection of disease-specific genes. M(3)Pv2.0 includes 77 genes selected for being either actionable targets, potentially related to drug-response or part of known key pathways in MM biology. We identified mutations in potentially actionable genes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
